House Bill Aims To Rein In State Drug, Device Inspections
The bill, H.R 4056, introduced Feb. 16, would clarify areas in the Federal Food, Drug and Cosmetic Act to delineate what inspections are governed by the FDA rather than state public health departments, including facility inspections and product recalls.
Although California is the only state that requires life sciences companies...
Already a subscriber? Click here to login